Caris Life Sciences President Spetzler David Baxley exercised Options for 1,250,000 shares at $2.44 per share. For investors, the transactions identify the exercise cost, sale-price range and resulting holdings, including 1,182,871 shares after sales and no remaining derivative securities.

Key Highlights

  • Baxley owned 1,302,083 shares after the option exercises.
  • The derivative securities were exercised at $0 per share.
  • The transactions covered both share sales and derivative securities.

Caris Life Sciences, Inc. (NASDAQ: CAI) President Spetzler David Baxley exercised options for 1,250,000 shares at $2.44 per share. The transactions were dated September 3 and September 4, with Baxley’s holdings reaching 1,302,083 shares after the exercises.

Baxley Reports Share Sales and Option Exercises

Separate transactions covered sales of 597,212 shares at prices ranging from $24.76 to $25.32 per share. Baxley’s reported share ownership after those sales was 1,182,871 shares. The transactions also covered 1,250,000 derivative securities exercised at $0 per share. The derivative securities position was reduced to none after those exercises. The filing identifies Baxley as president of Caris Life Sciences, Inc. and reports the share exercises, derivative securities exercises and sales between September 3 and September 4. The filing reported an exercise price of $2.44 per share and sale prices ranging from $24.76 to $25.32 per share. The ownership figures were reported separately after the exercises and after the sales.